Department of Preventive Medicine Center, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.
Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
J Gynecol Oncol. 2020 May;31(3):e55. doi: 10.3802/jgo.2020.31.e55. Epub 2020 Feb 26.
Cervical cancer is still one of the most common female cancers in Asia and the leading cause of cancer-related deaths in low- and middle-income countries. Nowadays, national screening programs for cervical cancer are widely provided in Asian countries. We reviewed the National Cancer Screening Program (NCSP) in China, India, Indonesia, Japan, Korea, and Thailand. The NCSP were established at varying times, from 1962 in Japan to 2014 in Indonesia. The primary screening method is based on cytology in all countries except for India and Indonesia. In India and Indonesia, visual inspection of the cervix with acetic acid (VIA) is mainly used as a primary screening method, and a "see and treat" strategy is applied to women with a positive VIA result. The starting age of NCSP ranges from 18 years in China to 30 years in Thailand. The screening interval is 2 years in all countries except for China and Indonesia, in which it is 3 years. Uptake rates of NCSP vary from 5.0%-59.7%. Many women in low- and middle-income countries still do not participate in NCSP. To improve uptake rates and thereby prevent more cases of cervical cancer, Asian countries should continue to promote NCSP to the public using various approaches.
宫颈癌仍然是亚洲女性最常见的癌症之一，也是中低收入国家癌症相关死亡的主要原因。如今，亚洲国家广泛提供宫颈癌国家筛查计划。我们回顾了中国、印度、印度尼西亚、日本、韩国和泰国的国家癌症筛查计划（NCSP）。NCSP 的建立时间各不相同，最早的是日本，于 1962 年建立，最晚的是印度尼西亚，于 2014 年建立。除了印度和印度尼西亚，所有国家的主要筛查方法都是细胞学检查。在印度和印度尼西亚，醋酸视觉检查（VIA）主要作为初级筛查方法，对 VIA 阳性结果的妇女采用“见治”策略。NCSP 的起始年龄范围从中国的 18 岁到泰国的 30 岁。除中国和印度尼西亚为 3 年外，所有国家的筛查间隔均为 2 年。NCSP 的参与率从 5.0%到 59.7%不等。许多中低收入国家的妇女仍然没有参加 NCSP。为了提高参与率，从而预防更多的宫颈癌病例，亚洲国家应继续通过各种途径向公众宣传 NCSP。
